Halozyme Therapeutics Inc. – Filings and Transcripts

NASDAQ: HALO
Share price (5/29/26): $66.54
Market cap (5/29/26): $7.893 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer

Ownership Filter

LaBrosse Nicole

Posard Matthew L.

Krishnan Mahesh

News Filter

Reports First Quarter 2026 Results and Reiterates 2026 Financial Guidance

Shareholder Vote Results

Appoints Darren Snellgrove as Chief Financial Officer

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Appoints David Ramsay as Interim Chief Financial Officer

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC